Warfarin therapeutic dose dependence on CYP2C9, CYP4F2, VKORC1 genes polymorphisms in patients with atrial fibrillation
| dc.contributor.author | Mykhailovskyi, Y. M. | |
| dc.contributor.author | Михайловський, Ярослав Максимович | |
| dc.date.accessioned | 2024-02-21T08:12:58Z | |
| dc.date.available | 2024-02-21T08:12:58Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Mykhailovskyi Y. Warfarin therapeutic dose dependence on CYP2C9, CYP4F2, VKORC1 genes polymorphisms in patients with atrial fibrillation / Ya. Mykhailovskyi ; Scientific supervisor: Prof. Dr. MD M. Kolesnik // 7th Lublin International Medical Congress for Students and Young Doctors : Abstracts, Lublin, 26th-28th November 2020. - Lublin, 2020. - P. 220. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/20095 | |
| dc.language.iso | en | uk_UK |
| dc.subject | atrial fibrillation | uk_UK |
| dc.subject | warfarin | uk_UK |
| dc.subject | genes polymorphism | uk_UK |
| dc.subject | dosing | uk_UK |
| dc.title | Warfarin therapeutic dose dependence on CYP2C9, CYP4F2, VKORC1 genes polymorphisms in patients with atrial fibrillation | uk_UK |
| dc.type | Other | uk_UK |